This trial is evaluating whether REAL INTELLIGENCE Tensioner will improve 1 primary outcome, 3 secondary outcomes, and 1 other outcome in patients with Arthroplasty. Measurement will happen over the course of During surgical procedure.
This trial requires 80 total participants across 1 different treatment group
This trial involves a single treatment. REAL INTELLIGENCE Tensioner is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Based on self-reported adverse events, this therapy is well tolerated in real intelligence tensioners, with no serious adverse events reported in more than 12% of treated patients." - Anonymous Online Contributor
"In the late 1980s and early 1990s, NTT (PSTO, Russia) and Siemens (Germany) developed an experimental real intelligence tensioner for therapeutic applications. Both groups of research and therapy products could not find market." - Anonymous Online Contributor
"Replacement therapy is rarely used for people with diabetes and no other diseases. A survey of people with diabetes from two primary care clinics found that only a small number received replacements or artificial limbs. There is a paucity of information about alternatives to replace." - Anonymous Online Contributor
"A key sign is enlargement of the urinary bladder (>20% of normal adult volume), which can cause low back pain and symptoms of obstructed defaecation." - Anonymous Online Contributor
"We found that the total number of primary replacement surgeries in 2009 was approximately 5,100 per 100,000 inhabitant-years. In 2007 and 2009, the number of total replacement surgeries was approximately 4,700 per 100,000 inhabitant-years. In 2010 there was a slight increase in the mean number of surgeries that year compared with 2007 (by about 5.5 percent per 100,000 inhabitant-years), although it was a relatively small difference when compared with the number of total replacements. Thus, there has been a reduction of the annual replacement rate of total replacements in the United States since 1998." - Anonymous Online Contributor
"The first two thirds of life in a man may be a good age for a replacement of a lower urinary tract procedure. Urinary tract symptoms appear at earlier ages in men with more than two urinary tract replacements." - Anonymous Online Contributor
"There is a large variance in the experience of subjects with respect to the outcome of the procedure. A large quantity of subjects (around two thirds of subjects) are optimistic with regard to the result. This has not been taken into account by the authorities in charge of selecting a surgery model. Replacement should be considered as a'stopgap' procedure which may be considered when more permanent solutions have failed to work." - Anonymous Online Contributor
"Replacement may be used in a variety of conditions including [osteoarthritis](https://www.withpower.com/clinical-trials/osteoarthritis), osteoporotic fractures, and arthritis. However, replacement is usually taken as an alternative to nonnarcotic medications that are more expensive but less effective. Replacement may offer no advantages over medications, but it may have an adverse impact on quality of life. It also may not be a cost-effective strategy." - Anonymous Online Contributor
"There was not enough evidence to conclude that, in any one clinical setting, either IA technique can prevent the tensioners. However, IA techniques might be usefully combined with other treatment, such as, surgery, antibiotics, or physiotherapy to help prevent the tensioners. It is best to follow up with your rehabilitation treatment and regular exercises." - Anonymous Online Contributor
"The tensioner was safe and effective in inducing rapid and large changes in IQ score that would require adjustment. The tensioner provides a useful tool in study design and for assessing real IQ change." - Anonymous Online Contributor
"The findings support the need to assess [intelligence tensioner beliefs and expectations on a periodic basis, during, at least the first year, after the commencement of therapy with antidepressants] during treatments as an integral part of the treatment package to be administered with depressive patients." - Anonymous Online Contributor
"Replacement of allografts is the main cause of allograft rejection from a population cohort study of a single-center. The primary cause appears to be recipient-specific cellular immunity." - Anonymous Online Contributor